Skip to main content
Fig. 1 | BMC Cancer

Fig. 1

From: Up-regulation of DGAT1 in cancer tissues and tumor-infiltrating macrophages influenced survival of patients with gastric cancer

Fig. 1

The expression of DGAT1 was elevated in gastric cancer patients and then decreased with cancer progression. a The expression of DGAT1 in pan-cancer (Superficial Bladder Cancer, n = 20; Myeloma, n = 20; Pancreatic Adenocarcinoma, n = 11; Papillary Renal Cell Carcinom, n = 16; Ovarian Serous Cystadenocarcinoma, n = 29; Gastric cancer, n = 20). b Comparison of DGAT1 expression between normal tissues and primary tumors in stomach adenocarcinoma patients (p = 0.25054). Comparison of DGAT1 expression upon different tumor grades (c) or individual cancer stages (d). *p < 0.05; ***p < 0.001. Tumor grades details: Grade 1: well differentiated (low grade); Grade 2: moderately differentiated (intermediate grade); Grade 3: poorly differentiated (high grade); Grade 4: undifferentiated (high grade). Data in (a) were collected from the Oncomine database, Data in (b-d) were collected from the UALCAN database

Back to article page